UnitedHealth Group Incorporated (NYSE:UNH) Position Increased by Northstar Group Inc.

Northstar Group Inc. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% during the 1st quarter, Holdings Channel reports. The fund owned 628 shares of the healthcare conglomerate’s stock after acquiring an additional 32 shares during the quarter. Northstar Group Inc.’s holdings in UnitedHealth Group were worth $329,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently added to or reduced their stakes in the business. Financial Management Professionals Inc. increased its position in UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock valued at $1,165,000 after acquiring an additional 17 shares during the period. Richwood Investment Advisors LLC increased its position in UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock valued at $2,654,000 after acquiring an additional 20 shares during the period. Global Wealth Strategies & Associates increased its position in shares of UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after purchasing an additional 20 shares during the period. 44 Wealth Management LLC increased its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after purchasing an additional 21 shares during the period. Finally, Prentice Wealth Management LLC increased its position in shares of UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate’s stock valued at $1,278,000 after purchasing an additional 21 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 1.6%

NYSE UNH opened at $313.39 on Monday. The company has a market capitalization of $284.28 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.44. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The stock’s 50 day moving average is $386.66 and its two-hundred day moving average is $472.32.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the firm posted $6.91 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. UnitedHealth Group’s dividend payout ratio is presently 37.02%.

Insider Buying and Selling

In related news, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John H. Noseworthy purchased 300 shares of the company’s stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the transaction, the director now directly owns 6,063 shares of the company’s stock, valued at approximately $1,892,626.08. This represents a 5.21% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of several research analyst reports. Oppenheimer lowered their price target on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 14th. Barclays lowered their price target on UnitedHealth Group to $350.00 and set an “overweight” rating on the stock in a research report on Monday, June 2nd. Truist Financial reiterated a “buy” rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. HSBC reissued a “reduce” rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Finally, KeyCorp reduced their price objective on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $426.52.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.